Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by qwerty22on Dec 01, 2021 11:07am
105 Views
Post# 34184991

RE:RE:RE:Hiv at 40 video

RE:RE:RE:Hiv at 40 video

Terrence Higgins trust is the biggest uk hiv charity, dating back to the start of the disease. They've certainly partnered with the biggest names. Seems like Paul's approach to marketing is to engage with stakeholders. I remember when he first joined thtx reading about  his views on the rare disease space which he came from, the trick was engagement with the community. You can certainly think of thtx drugs as niche and he's applying this approach to those drugs.


SPCEO1 wrote: Completely at the opposite end of spectrum from a production values perspective. I wonder what the back story for this is? You likely saw the three names on the screen at the start of the video - did they sponsor it? Was this part of an effort to get TH's brand established in the UK before Trogarzo is launched there?
 

qwerty22 wrote:


In case people don't know ITN is the leading commercial network TV company in the UK, behind the bbc. Possibly the leading production company in uk TV. It's a helluva step up from that recent video they put out!
 




<< Previous
Bullboard Posts
Next >>